Papers
21
Total Citations
299
H-Index
11
About
Stefano Luzzago is a leading urologic oncologist whose research focuses on advancing robotic surgery for prostate, kidney, and bladder cancers. His work has garnered over 200 citations, with his most influential study on in-hospital length of stay after major surgical oncological procedures (44 citations) helping to optimize perioperative care pathways. Luzzago has made landmark contributions to renal cancer management, demonstrating through long-term follow-up that robot-assisted partial nephrectomy in elderly patients achieves excellent oncologic and functional outcomes (35 citations), while his 5-year outcomes study at a European tertiary center (26 citations) established benchmarks for this approach. He has also pioneered comparative effectiveness research in bladder cancer, showing that intracorporeal neobladder construction during robot-assisted radical cystectomy offers advantages over extracorporeal techniques (24 citations). Notably, Luzzago developed a novel nomogram incorporating multiparametric MRI findings to predict lymph node invasion in prostate cancer (18 citations), and his first-in-human validation of a DROP-IN β-probe for robotic radioguided surgery (14 citations) represents cutting-edge work in intraoperative imaging. His comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for testicular cancer (16 citations) addresses critical quality-of-life concerns. Through these contributions, Luzzago continues to refine surgical techniques, improve patient selection, and enhance functional outcomes across the spectrum of urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1In-hospital length of stay after major surgical oncological procedures44 citations · 2018
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10